Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 94

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Death squads enlisted by the tumour suppressor p53

Michalak, Ewa, Villunger, Andreas, Erlacher, Miriam, Strasser, Andreas · 2005 · Biochemical and Biophysical Research Communications

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbrc.2005.03.183

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 112

  1. Levine, 1997, p53, the cellular gatekeeper for growth and division, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1 · DOI · Paper page
  2. Vousden, 2002, Live or let die: the cell’s response to p53, Nat. Rev. Cancer, 2, 594, 10.1038/nrc864 · DOI · Paper page
  3. Jacks, 1994, Tumor spectrum analysis in p53-mutant mice, Curr. Biol., 4, 1, 10.1016/S0960-9822(00)00002-6 · DOI · Paper page
  4. Vogelstein, 2000, Surfing the p53 network, Nature, 408, 307, 10.1038/35042675 · DOI · Paper page
  5. Javelaud, 2002, Inactivation of p21WAF1 sensitizes cells to apoptosis via an increase of both p14ARF and p53 levels and an alteration of the Bax/Bcl-2 ratio, J. Biol. Chem., 277, 37949, 10.1074/jbc.M204497200 · DOI
  6. Yonish-Rouach, 1991, Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6, Nature, 352, 345, 10.1038/352345a0 · DOI · Paper page
  7. Shaw, 1992, Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line, Proc. Natl. Acad. Sci. USA, 89, 4495, 10.1073/pnas.89.10.4495 · DOI · Paper page
  8. Ramqvist, 1993, Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53, Oncogene, 8, 1495
  9. Johnson, 1993, Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin, Mol. Cell. Biol., 13, 1456, 10.1128/MCB.13.3.1456 · doi:10.1128/mcb.13.3.1456
  10. Clarke, 1993, Thymocyte apoptosis induced by p53-dependent and independent pathways, Nature, 362, 849, 10.1038/362849a0 · DOI · Paper page
  11. Strasser, 1994, DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2, Cell, 79, 329, 10.1016/0092-8674(94)90201-1 · DOI · Paper page
  12. Merritt, 1994, The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice, Cancer Res., 54, 614
  13. Debbas, 1993, Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B, Genes Dev., 7, 546, 10.1101/gad.7.4.546 · DOI · Paper page
  14. Lowe, 1993, Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis, Genes Dev., 7, 535, 10.1101/gad.7.4.535 · DOI · Paper page
  15. Wagner, 1994, Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1, Genes Dev., 8, 2817, 10.1101/gad.8.23.2817 · DOI · Paper page
  16. Wu, 1994, p53 and E2F-1 cooperate to mediate apoptosis, Proc. Natl. Acad. Sci. USA, 91, 3602, 10.1073/pnas.91.9.3602 · DOI · Paper page
  17. Berns, 2004, A large-scale RNAi screen in human cells identifies new components of the p53 pathway, Nature, 428, 431, 10.1038/nature02371 · DOI · Paper page
  18. Oda, 2000, p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53, Cell, 102, 849, 10.1016/S0092-8674(00)00073-8 · DOI · Paper page
  19. Matsuda, 2002, p53AIP1 regulates the mitochondrial apoptotic pathway, Cancer Res., 62, 2883
  20. Okamura, 2001, p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis, Mol. Cell, 8, 85, 10.1016/S1097-2765(01)00284-2 · DOI · Paper page
  21. Takekawa, 2000, p53-inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation, EMBO J., 19, 6517, 10.1093/emboj/19.23.6517 · DOI · Paper page
  22. Bernards, 2004, Wip-ing out cancer, Nat. Genet., 36, 319, 10.1038/ng0404-319 · DOI
  23. Freeman, 2003, PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms, Cancer Cell, 3, 117, 10.1016/S1535-6108(03)00021-7 · DOI · Paper page
  24. Di Cristofano, 2000, The multiple roles of PTEN in tumor suppression, Cell, 100, 387, 10.1016/S0092-8674(00)80674-1 · DOI · Paper page
  25. Di Cristofano, 1998, Pten is essential for embryonic development and tumour suppression, Nat. Genet., 19, 348, 10.1038/1235 · DOI · Paper page
  26. Stambolic, 2001, Regulation of PTEN transcription by p53, Mol. Cell, 8, 317, 10.1016/S1097-2765(01)00323-9 · DOI · Paper page
  27. Stambolic, 1998, Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN, Cell, 95, 29, 10.1016/S0092-8674(00)81780-8 · DOI · Paper page
  28. Velasco-Miguel, 1999, PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes, Oncogene, 18, 127, 10.1038/sj.onc.1202274 · DOI · Paper page
  29. Budanov, 2002, Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability, Oncogene, 21, 6017, 10.1038/sj.onc.1205877 · DOI · Paper page
  30. Budanov, 2004, Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD, Science, 304, 596, 10.1126/science.1095569 · DOI · Paper page
  31. Yoon, 2004, Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses, J. Hum. Genet., 49, 134, 10.1007/s10038-003-0122-3 · DOI · Paper page
  32. Polyak, 1997, A model for p53-induced apoptosis, Nature, 389, 300, 10.1038/38525 · DOI · Paper page
  33. Lehar, 1996, Identification and cloning of EI24, a gene induced by p53 in etoposide-treated cells, Oncogene, 12, 1181
  34. Gentile, 2001, Candidate tumour suppressor genes at 11q23-q24 in breast cancer: evidence of alterations in PIG8, a gene involved in p53-induced apoptosis, Oncogene, 20, 7753, 10.1038/sj.onc.1204993 · DOI
  35. Gu, 2000, ei24, a p53 response gene involved in growth suppression and apoptosis, Mol. Cell. Biol., 20, 233, 10.1128/MCB.20.1.233-241.2000 · DOI
  36. Flatt, 2000, p53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest, Cancer Lett., 156, 63, 10.1016/S0304-3835(00)00441-9 · DOI
  37. Hwang, 2001, Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells, Nat. Med., 7, 1111, 10.1038/nm1001-1111 · DOI · Paper page
  38. Breckenridge, 2003, Regulation of apoptosis by endoplasmic reticulum pathways, Oncogene, 22, 8608, 10.1038/sj.onc.1207108 · DOI · Paper page
  39. Adachi, 2004, Identification of SCN3B as a novel p53-inducible proapoptotic gene, Oncogene, 23, 7791, 10.1038/sj.onc.1208067 · DOI
  40. Bourdon, 2002, Scotin, a novel p53-inducible proapoptotic protein located in the ER and the nuclear membrane, J. Cell Biol., 158, 235, 10.1083/jcb.200203006 · DOI
  41. Buckbinder, 1995, Induction of the growth inhibitor IGF-binding protein 3 by p53, Nature, 377, 646, 10.1038/377646a0 · DOI · Paper page
  42. Attardi, 2000, PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family, Genes Dev., 14, 704, 10.1101/gad.14.6.704 · DOI · Paper page
  43. Ashkenazi, 1998, Death receptors: signaling and modulation, Science, 281, 1305, 10.1126/science.281.5381.1305 · DOI · Paper page
  44. Strasser, 2000, Apoptosis signaling, Annu. Rev. Biochem., 69, 217, 10.1146/annurev.biochem.69.1.217 · DOI · Paper page
  45. Owen-Schaub, 1995, Wild-type human p53 and a temperature-sensitive mutant induce FAS/APO-1 expression, Mol. Cell. Biol., 15, 3032, 10.1128/MCB.15.6.3032 · DOI · Paper page
  46. Bennett, 1998, Cell surface trafficking of FAS: a rapid mechanism of p53-mediated apoptosis, Science, 282, 290, 10.1126/science.282.5387.290 · DOI · Paper page
  47. Strasser, 1995, Bcl-2 and FAS/APO-1 regulate distinct pathways to lymphocyte apoptosis, EMBO J., 14, 6136, 10.1002/j.1460-2075.1995.tb00304.x · DOI · Paper page
  48. O’Connor, 1999, FAS, p53, and apoptosis, Science, 284, 1430
  49. Guan, 2001, Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene, J. Cell. Physiol., 188, 98, 10.1002/jcp.1101 · DOI
  50. Wu, 1997, KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene, Nat. Genet., 17, 141, 10.1038/ng1097-141 · DOI · Paper page
  51. Sheikh, 1999, The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract, Oncogene, 18, 4153, 10.1038/sj.onc.1202763 · DOI
  52. Meng, 2000, The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis, Mol. Ther., 1, 130, 10.1006/mthe.2000.0025 · DOI
  53. Ruiz de Almodovar, 2004, Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) decoy receptor TRAIL-R3 is up-regulated by p53 in breast tumor cells through a mechanism involving an intronic p53-binding site, J. Biol. Chem., 279, 4093, 10.1074/jbc.M311243200 · DOI
  54. Newton, 1998, A dominant interfering mutant of FADD/Mort1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes, EMBO J., 17, 706, 10.1093/emboj/17.3.706 · DOI · Paper page
  55. Newton, 2000, Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of FAS or FADD/MORT1 signaling: implications for cancer therapy, J. Exp. Med., 191, 195, 10.1084/jem.191.1.195 · DOI
  56. Yeh, 1998, FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis, Science, 279, 1954, 10.1126/science.279.5358.1954 · DOI · Paper page
  57. Zhang, 1998, FAS-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1, Nature, 392, 296, 10.1038/32681 · DOI · Paper page
  58. Smith, 1996, CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (FAS/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease, EMBO J., 15, 5167, 10.1002/j.1460-2075.1996.tb00901.x · DOI · Paper page
  59. Varfolomeev, 1998, Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, FAS/Apo1, and DR3 and is lethal prenatally, Immunity, 9, 267, 10.1016/S1074-7613(00)80609-3 · DOI · Paper page
  60. Salmena, 2003, Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity, Genes Dev., 17, 883, 10.1101/gad.1063703 · DOI · Paper page
  61. Kang, 2004, Caspase-8 serves both apoptotic and nonapoptotic roles, J. Immunol., 173, 2976, 10.4049/jimmunol.173.5.2976 · DOI · Paper page
  62. Ashkenazi, 1999, Safety and antitumor activity of recombinant soluble Apo2 ligand, J. Clin. Invest., 104, 155, 10.1172/JCI6926 · DOI · Paper page
  63. Wang, 2001, The expanding role of mitochondria in apoptosis, Genes Dev., 15, 2922
  64. Ekert, 2004, Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die, J. Cell Biol., 165, 835, 10.1083/jcb.200312031 · DOI · Paper page
  65. Marsden, 2004, Bcl-2-regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9, J. Cell Biol., 165, 775, 10.1083/jcb.200312030 · DOI
  66. Huang, 2000, BH3-only proteins—essential initiators of apoptotic cell death, Cell, 103, 839, 10.1016/S0092-8674(00)00187-2 · DOI · Paper page
  67. Strasser, 1991, Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship, Cell, 67, 889, 10.1016/0092-8674(91)90362-3 · DOI · Paper page
  68. Wang, 1993, Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line, Oncogene, 8, 3427
  69. Rathmell, 2002, Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis, Nat. Immunol., 3, 932, 10.1038/ni834 · DOI · Paper page
  70. Jeffers, 2003, Puma is an essential mediator of p53-dependent and -independent apoptotic pathways, Cancer Cell, 4, 321, 10.1016/S1535-6108(03)00244-7 · DOI · Paper page
  71. Robles, 2001, APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis, Cancer Res., 61, 6660
  72. Zhou, 1999, HAC-1, a Drosophila homolog of APAF-1 and CED-4 functions in developmental and radiation-induced apoptosis, Mol. Cell, 4, 745, 10.1016/S1097-2765(00)80385-8 · DOI · Paper page
  73. Soengas, 1999, Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition, Science, 284, 156, 10.1126/science.284.5411.156 · DOI · Paper page
  74. Scott, 2004, Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation, J. Cell Biol., 164, 89, 10.1083/jcb.200310041 · DOI
  75. Telliez, 2000, LRDD, a novel leucine rich repeat and death domain containing protein, Biochim. Biophys. Acta, 1478, 280, 10.1016/S0167-4838(00)00029-7 · DOI
  76. Lin, 2000, Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis, Nat. Genet., 26, 124, 10.1038/79102 · DOI · Paper page
  77. Tinel, 2004, The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress, Science, 304, 843, 10.1126/science.1095432 · DOI · Paper page
  78. O’Reilly, 2002, Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9, Cell Death Differ., 9, 832, 10.1038/sj.cdd.4401033 · DOI · Paper page
  79. Selvakumaran, 1994, Immediate early up-regulation of bax expression by p53 but not TGFb1: a paradigm for distinct apoptotic pathways, Oncogene, 9, 1791
  80. Miyashita, 1994, Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo, Oncogene, 9, 1799
  81. Han, 1996, The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein, Genes Dev., 10, 461, 10.1101/gad.10.4.461 · DOI · Paper page
  82. Attardi, 1996, Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis, EMBO J., 15, 3693, 10.1002/j.1460-2075.1996.tb00739.x · DOI · Paper page
  83. Sakamuro, 1997, The polyproline region of p53 is required to activate apoptosis but not growth arrest, Oncogene, 15, 887, 10.1038/sj.onc.1201263 · DOI · Paper page
  84. Marchenko, 2000, Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling, J. Biol. Chem., 275, 16202, 10.1074/jbc.275.21.16202 · DOI · Paper page
  85. Mihara, 2003, p53 has a direct apoptogenic role at the mitochondria, Mol. Cell, 11, 577, 10.1016/S1097-2765(03)00050-9 · DOI · Paper page
  86. Leu, 2004, Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex, Nat. Cell Biol., 6, 443, 10.1038/ncb1123 · DOI · Paper page
  87. Sellins, 1987, Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes, J. Immunol., 139, 3199, 10.4049/jimmunol.139.10.3199 · DOI · Paper page
  88. Chao, 2000, p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage, EMBO J., 19, 4967, 10.1093/emboj/19.18.4967 · DOI · Paper page
  89. Jimenez, 2000, A transactivation-deficient mouse model provides insights into TrP53 regulation and function, Nat. Genet., 26, 37, 10.1038/79152 · DOI · Paper page
  90. O’Connor, 1998, Bim: a novel member of the Bcl-2 family that promotes apoptosis, EMBO J., 17, 384, 10.1093/emboj/17.2.384 · DOI · Paper page
  91. Bouillet, 1999, Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity, Science, 286, 1735, 10.1126/science.286.5445.1735 · DOI · Paper page
  92. Bouillet, 2001, Degenerative disorders caused by Bcl-2 deficiency are prevented by loss of its BH3-only antagonist Bim, Dev. Cell, 1, 645, 10.1016/S1534-5807(01)00083-1 · DOI · Paper page
  93. Egle, 2004, Bim is a suppressor of Myc-induced mouse B cell leukemia, Proc. Natl. Acad. Sci. USA, 101, 6164, 10.1073/pnas.0401471101 · DOI · Paper page
  94. Puthalakath, 2002, Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins, Cell Death Differ., 9, 505, 10.1038/sj.cdd.4400998 · DOI · Paper page
  95. Shibue, 2003, Integral role of Noxa in p53-mediated apoptotic response, Genes Dev., 17, 2233, 10.1101/gad.1103603 · DOI · Paper page
  96. Schuler, 2003, p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation, Cell Death Differ., 10, 451, 10.1038/sj.cdd.4401180 · DOI
  97. Jansson, 2003, Noxa in colorectal cancer: a study on DNA, mRNA and protein expression, Oncogene, 22, 4675, 10.1038/sj.onc.1206655 · DOI
  98. Lee, 2003, Mutational analysis of Noxa gene in human cancers, APMIS, 111, 599, 10.1034/j.1600-0463.2003.1110602.x · DOI
  99. Kim, 2004, BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha, J. Exp. Med., 199, 113, 10.1084/jem.20030613 · DOI · Paper page
  100. Yu, 2001, PUMA induces the rapid apoptosis of colorectal cancer cells, Mol. Cell, 7, 673, 10.1016/S1097-2765(01)00213-1 · DOI · Paper page
  101. Nakano, 2001, PUMA, a novel proapoptotic gene, is induced by p53, Mol. Cell, 7, 683, 10.1016/S1097-2765(01)00214-3 · DOI · Paper page
  102. Han, 2001, Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals, Proc. Natl. Acad. Sci. USA, 98, 11318, 10.1073/pnas.201208798 · DOI · Paper page
  103. Yu, 2003, PUMA mediates the apoptotic response to p53 in colorectal cancer cells, Proc. Natl. Acad. Sci. USA, 100, 1931, 10.1073/pnas.2627984100 · DOI · Paper page
  104. Hemann, 2004, Suppression of tumorigenesis by the p53 target PUMA, Proc. Natl. Acad. Sci. USA, 101, 9333, 10.1073/pnas.0403286101 · DOI · Paper page
  105. Furuhata, 1996, Isolation of a novel GPI-anchored gene specifically regulated by p53; correlation between its expression and anti-cancer drug sensitivity, Oncogene, 13, 1965
  106. Hofer-Warbinek, 2004, A highly conserved proapoptotic gene, IKIP, located next to the APAF1 gene locus, is regulated by p53, Cell Death Differ., 10.1038/sj.cdd.4401502 · DOI
  107. Fernandez-Salas, 2002, mtCLIC/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53, Mol. Cell. Biol., 22, 3610, 10.1128/MCB.22.11.3610-3620.2002 · DOI · Paper page
  108. Urano, 1997, Cloning of P2XM, a novel human P2X receptor gene regulated by p53, Cancer Res., 57, 3281
  109. Ohiro, 2002, A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF), FEBS Lett., 524, 163, 10.1016/S0014-5793(02)03049-1 · DOI
  110. Wu, 2002, AMID, an apoptosis-inducing factor-homologous mitochondrion-associated protein, induces caspase-independent apoptosis, J. Biol. Chem., 277, 25617, 10.1074/jbc.M202285200 · DOI · Paper page
  111. Fortin, 2004, The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1, J. Biol. Chem., 279, 28706, 10.1074/jbc.M400376200 · DOI
  112. Ng, 1999, Isolation and characterization of a novel TP53-inducible gene, TP53TG3, Genes Chromosomes Cancer, 26, 329, 10.1002/(SICI)1098-2264(199912)26:4<329::AID-GCC7>3.0.CO;2-C · DOI

Cited by

See all 94

Metadata

Authors
Michalak, E., Villunger, A., Erlacher, M., & Strasser, A.
Venue
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Published
2005-06
Volume
331
Issue
3
Pages
786-798
ISSN
0006-291X
Cited by
94
References
25
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.